KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
Alaa T. Alshareeda(King Abdulaziz Medical City), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Ola H. Negm(University of Nottingham), Nada Albarakati(University of Nottingham), Ian O. Ellis(University of Nottingham), Patrick J. Tighe(University of Florida), Andrew R. Green(Nottingham Biomedical Research Centre), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Christopher C. Nolan(University of Nottingham), Rebeka Sultana(University of Nottingham)
Cited by 76
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Clinical and genetic characteristics of hereditary pancreatitis in Europe
|Clinical Gastroenterology and Hepatology|2004|615